Mkts

bioAffinity Technologies, Inc.

NASDAQ: BIAF
$3.73-0.23 (-5.81%)
As of Oct 16, 4:00 PM ET

Key statistics

Day range
3.603.95
52-week range
3.2380.70
Today
Open3.95
Previous close3.73
Volume—
Valuation
Market cap4.79M
P/E ratio—
EPS (TTM)-6.89
Income & risk
Dividend / yield—
Beta-1.17
Avg volume2.65M
Discussion

BIAF News

Stories mentioning BIAF from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue1,3521,5931,4461,2691,8542,2082,3502,398
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development350.00374.00331.00311.00367.00391.00274.00402.00
Sales General & Admin3,2423,0372,2092,2152,4532,9192,3652,473
Total Operating Expenses4,9694,7293,7393,7854,4815,1544,3244,485
Operating Income (Loss)(3,617)(3,137)(2,293)(2,516)(2,627)(2,946)(1,974)(2,088)
Interest Income10.0019.001.002.001.005.002.005.00
Interest Expense
Other Expense0.00
Pretax Income(3,631)(3,134)(5,048)(4,032)(2,652)(2,967)(1,998)(2,105)
Tax Provision3.003.0029.009.000.003.005.00
Net Income (Loss)(3,631)(3,138)(5,051)(4,061)(2,660)(2,967)(2,001)(2,110)
Earnings Per Share (Basic)(0.81)(1.82)(4.74)(0.17)(4.80)(7.34)(4.84)(0.19)
Earnings Per Share (Diluted)(0.81)(1.82)(4.74)(0.17)(4.80)(7.34)(4.84)(0.19)
Weighted Average Shares Outstanding (Basic)4,4951,7211,06624,022542.00404.00413.0011,389
Weighted Average Shares Outstanding (Diluted)4,4951,7211,06624,022542.00404.00413.0011,389

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About BIAF

bioAffinity Technologies, Inc. (NASDAQ: BIAF) is a stock listed on the Nasdaq Stock Market under the ticker symbol BIAF. It last traded at $3.73 (Oct 16, 2026, 4:00 PM ET), down 5.8% on the day. That gives bioAffinity Technologies a market capitalisation of $4.8M.

Over the past 52 weeks BIAF has traded between $3.23 and $80.70.

Revenue for the quarter ended Mar 31, 2026 was $1.4M; a net loss of $3.6M. Revenue was down 27.1% from $1.9M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$1.4M-$3.6M-268.6%
Dec 31, 2025$1.6M-$3.1M-197.0%
Sep 30, 2025$1.4M-$5.1M-349.3%
Jun 30, 2025$1.3M-$4.1M-320.0%

From bioAffinity Technologies’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…